STAMFORD, Conn.--(BUSINESS WIRE)--

Alliance for Cancer Gene Therapy, Inc. (ACGT), http://www.acgtfoundation.org, https://twitter.com/acgtfoundation, and https://www.facebook.com/acgtfoundation, today announced that its inaugural Symposium Gene and Cell Therapy For Cancer held recently at the 16th Annual American Society of Gene and Cell Therapy Meeting in Salt Lake City, Utah, boasted more than 300 attendees.

We are strongly encouraged by the significant progress that is being made in the area of cell and gene therapies for cancer, said Barbara Netter, ACGT President and Co-Founder. She added, It has been a little over a decade since ACGT provided seed money in the form of grants to Young Investigators to conduct this critical lifesaving research. Today, we are joined by multi-national pharmaceutical companies that are investing in this research, further reinforcing the importance of our continued investment.

The ACGT Symposium, co-chaired by Xandra O. Breakefield, PhD, Massachusetts General Hospital, outgoing ASGCT President, and Savio L.C. Woo, PhD, Mount Sinai School of Medicine, both ACGT Scientific Advisory Council members, featured four members of ACGTs Scientific Advisory Council who showcased the significant progress that is being made and future potential for cell and gene therapies for cancer. ACGT was also well represented at the Conference, with six other scientists presenting at other panels, and several others as authors of abstracts. ACGT is also proud to note that three of its Young Investigators have also been recognized by ASCGT as Outstanding New Investigators.

Speakers and Topics Included:

ACGT is the nations only not-for-profit organization solely dedicated to cell and gene therapy research for all types of cancer. To donate, please visit http://www.acgtfoundation.org or call 203.358.8000.

Visit link:

Alliance for Cancer Gene Therapy Boasts Standing Room Only Turnout at the 16th Annual American Society of Gene and ...